Adeno-associated viral vectors (AAVs) have been demonstrated to be safe and effective gene delivery system in preclinical and clinical gene therapies of Parkinson's disease (PD). As a leading service provider in the field of gene therapy, Creative Biolabs has a professional expert team with extensive experience and advanced technology platforms to offer a full range of AAV design and engineering services for the gene therapy of PD.
https://www.creative-biolabs.com/gene-therapy/parkinson-s-disease-pd.htm